Introduction
The research group works in the design, synthesis and biological assessment of pharmacologically active compounds opposite to different pharmacological targets related to anticancer (Glioma inhibitor), antihyperpigmentation (Tyrosinase Inhibitor) and antiosteoporosis (C-Telopeptide inhibitors).
The design is carried out through the use of different computational tools such as auto-docking, and molecular dynamics. The designed compounds are synthetised and enzymatic inhibition and celular proliferation in tumor cell lines trials are carried out. The affinity for its target is studied by docking simulations. It is a cyclical process to be able to establish a structure-activity relation in each of the compounds.
Mission
- Providing expertise, consultation and experience in areas of drug synthesis and purification.
- Providing custom synthesis and support for the development of small molecule tools or the synthesis of known ligands or probes  which are not commercially available.
- Synthesis of materials for pre-clinical investigations.
- Support for small-molecule drug discovery through optimization of leads identified in high throughput screens.
Aim
Over the past years, fewer compounds were synthetized as the design becomes more focused, principally using computer-aided techniques. As a consequence, synthetic chemists are asked to develop new synthetic routes that can be redesigned rapidly.
Useful Information
Looking forward to connecting with you! Don’t hesitate to reach out.
Physical Address​
Pharmaceutical Chemistry Laboratory Faculty of Pharmacy, Perintis Kemerdekaan Street, Km 10 Tamalanrea, Makassar, Hasanuddin University
yusnita@fmipa.unhas.ac.id
Phone Numbers | WhatsApps
O82196562691
Send us your Feedback
We value your opinions! Share your feedback to help us improve and grow. Whether it’s about our research, website, or events, your insights are important to us.

